Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.61T
24h Vol:
$3.48B
Dominance:
MSFT:5.14%
Stocklytics Platform
BETA
Instrument logo  AMGN

Amgen Inc

AMGN
67 / 100
S&P500
$279.60arrow_drop_down-2.36%-$6.77
Key Stats
Open$286.51
Prev. Close$285.17
EPS12.49
Dividend$8.52
Next Earnings DateJun 5, 2024
Dividend Yield %3.11%
Market Cap$154.97B
PE Ratio23.15
LOWHIGH
Day Range286.01
292.23
52 Week Range211.71
329.72
Ratios
P/B Ratio24.87
Revenue$28.19B
Operating M. %8.15%
Earnings$6.71B
Earnings Growth %2.52%
EBITDA Margin %43.40%
ROE %135.79%
EPS12.49
Fundamentals
RPS$52.69
Gross Profit$19.73B
EBITDA$14.80B
Total Debt$65.42B
P/S Ratio5.5x
Enterprise to EBITDA14.10
Profit Margin23.83%
ROA6.29%
Debt/Equity Ratio10.50%
Payout Ratio46.33%
Industry average yield3.04%
Last Dividend pay dateMar 7, 2024
Dividend per share$8.52
Dividend yield forecast0.03%

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

AMGNarrow_drop_up1.40%
US Healthcare Sectorarrow_drop_up0.65%
US Marketarrow_drop_up0.51%
AMGN / Market
AMGN exceeded the US Market which returned 0.51% over the last twenty four hours.
AMGN / Healthcare Sector
AMGN exceeded the US Healthcare sector which returned 0.65% over the last twenty four hours.

Amgen Inc (AMGN) Statistics

Amgen Inc, also known as AMGN, is a biotechnology company that specializes in developing and manufacturing human therapeutics. As of the latest valuation metrics, AMGN has a market capitalization of around $139 billion. The company's valuation is determined by various factors such as its revenue growth, profitability, and overall financial health. When analyzing the fundamentals of Amgen Inc, it is essential to consider key metrics such as its revenue per share, enterprise to EBITDA ratio, profit margin, total debt, and gross profit. These metrics provide insights into the company's financial performance and stability.

In terms of stock performance compared to its sector, AMGN has shown resilience and strong growth. Despite facing industry challenges, Amgen Inc has managed to outperform its peers and deliver solid returns to investors. The company's dedication to research and development, as well as its robust product portfolio, have contributed to its success in the market. When examining the revenue per share, Amgen Inc has consistently demonstrated its ability to generate substantial revenue. This indicates that the company has a strong customer base and demand for its products.

add Amgen Inc to watchlist

Keep an eye on Amgen Inc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
What is the EBITDA of Amgen Inc (AMGN) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Amgen Inc (AMGN) is $14.8B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

question_mark
How much debt does Amgen Inc (AMGN) have?

Amgen Inc (AMGN) has a total debt of $65.42B. The net debt, which accounts for cash and cash equivalents against the total debt, is $53.67B.

question_mark
How has Amgen Inc (AMGN) stock's performance compared to its sector and the market over the past year?

Over the past year, Amgen Inc (AMGN) has experienced a price change of 23.32%. Compared to the Healthcare sector, which saw a change of 35.20%, Amgen Inc has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 39.12%, it has fallen short of the market average. This comparison highlights Amgen Inc's performance relative to both its sector and the overall market over the last year.

question_mark
What is the PE ratio of Amgen Inc (AMGN) stock?

The PE (Price to Earnings) ratio of Amgen Inc (AMGN) is currently 23.15. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.

question_mark
What is the EPS of Amgen Inc (AMGN) stock?

The Earnings Per Share (EPS) for Amgen Inc (AMGN), calculated on a diluted basis, is $12.49. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

question_mark
What is the operating margin of Amgen Inc (AMGN) stock?

The operating margin for Amgen Inc (AMGN) is 8.15%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.